BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16133023)

  • 1. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
    Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase expression in sebaceous carcinoma of the eyelid.
    Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX
    Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telomerase expression in tarsal gland carcinoma].
    Li N; Li B; Sun X; Li L; Chen C
    Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):684-7. PubMed ID: 12487901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of telomerase genes in human tumors].
    Yuan X; Zhang B; Ying J; Jin Y; Hou L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):16-9. PubMed ID: 11866885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
    Jakobiec FA; Mendoza PR
    Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
    Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Yunoki T; Tabuchi Y; Hayashi A
    Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
    Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
    Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
    Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
    Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
    Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
    Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sebaceoma of the eyelid.
    Yonekawa Y; Jakobiec FA; Zakka FR; Fay A
    Ophthalmology; 2012 Dec; 119(12):2645.e1-4. PubMed ID: 23207023
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid.
    Rigas PK; Kase S; Rao NA
    Eur J Ophthalmol; 2009; 19(5):702-7. PubMed ID: 19787585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
    Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.